State-of-the-art R&D support from conceptualization, research to product development

Heterologous expression

2 5   heterWe offer our clients the utilization of our highly efficient in-house developed heterologous expression systems based on Actinomyces and Bacillus high-producing strains to service your needs. Our optimized high-producing industrial hosts allow for efficient heterologous expression of large gene clusters encoding complex biosynthesis of secondary metabolites, as well as for heterologous expression of target proteins for production of biopharmaceuticals or industrially relevant enzymes.

Please read more about our heterologous expression platform here...

Acies was part of Bio World 2017, a unique forum for industry global leaders, policy makers and investors.  
The action is co-financed by the Republic of Slovenia and European Union from European Regional Development Fund.

More >>
Within public call "Enhancing innovation potential and competences in companies", Acies Bio was recognised as one of the innovative companies with best potential to contribute to international competitiveness of Slovenia through smart specialisation.

More >>